Cited by 274Effects and risks of endocrine disrupting chemicalsHealth, Environment, Cognitive AgingToxic Organic Pollutants Impact

Association of Urinary Concentrations of Bisphenol A and Phthalate Metabolites with Risk of Type 2 Diabetes: A Prospective Investigation in the Nurses’ Health Study (NHS) and NHSII Cohorts

Open access
Sun, Qi, Cornelis, Marilyn C., Townsend, Mary K., Tobias, Deirdre K., Eliassen, A. Heather, Franke, Adrian A., Hauser, Russ, Hu, Frank B.·2014·Environmental Health Perspectives

Abstract

Background: Prospective evidence regarding associations for exposures to bisphenol A (BPA) and phthalates with type 2 diabetes (T2D) is lacking. Objective: We prospectively examined urinary concentrations of BPA and phthalate metabolites with T2D risk. Methods: We measured BPA and eight major phthalate metabolites among 971 incident T2D case–control pairs from the Nurses’ Health Study (NHS) (mean age, 65.6 years) and NHSII (mean age, 45.6 years). Results: In the NHSII, BPA levels were not associated with incident T2D in multivariate-adjusted analysis until body mass index was adjusted: odds ratio (OR) comparing extreme BPA quartiles increased from 1.40 (95% CI: 0.91, 2.15) to 2.08 (95% CI: 1.17, 3.69; ptrend = 0.02) with such an adjustment. In contrast, BPA concentrations were not associated with T2D in the NHS (OR = 0.81; 95% CI: 0.48, 1.38; ptrend = 0.45). Likewise, urinary concentrations of total phthalate metabolites were associated with T2D in the NHSII (OR comparing extreme quartiles = 2.14; 95% CI: 1.19, 3.85; ptrend = 0.02), but not in the NHS (OR = 0.87; 95% CI: 0.49, 1.53; ptrend = 0.29). Summed metabolites of butyl phthalates or di-(2-ethylhexyl) phthalates were significantly associated with T2D only in the NHSII; ORs comparing extreme quartiles were 3.16 (95% CI: 1.68, 5.95; ptrend = 0.0002) and 1.91 (95% CI: 1.04, 3.49; ptrend = 0.20), respectively. Conclusions: These results suggest that BPA and phthalate exposures may be associated with the risk of T2D among middle-aged, but not older, women. The divergent findings between the two cohorts might be explained by menopausal status or simply by chance. Clearly, these results need to be interpreted with caution and should be replicated in future studies, ideally with multiple urine samples collected prospectively to improve the measurement of these exposures with short half-lives. Citation: Sun Q, Cornelis MC, Townsend MK, Tobias DK, Eliassen AH, Franke AA, Hauser R, Hu FB. 2014. Association of urinary concentrations of bisphenol A and phthalate metabolites with risk of type 2 diabetes: a prospective investigation in the Nurses’ Health Study (NHS) and NHSII Cohorts. Environ Health Perspect 122:616–623; http://dx.doi.org/10.1289/ehp.1307201

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1289/ehp.1307201

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Epidemiological studies in the US reported that women with higher urinary concentrations of MBP, MiBP, MBzP, and MCPP and those of DEHP metabolites showed increased risk of diagnosis for diabetes compared with those who had lower concentrations.

    “Epidemiological studies in the US [192,193] reported that women with higher urinary concentrations of MBP, MiBP, MBzP, and MCPP and those of DEHP metabolites showed increased risk of diagnosis for diabetes in comparison with those who had lower concentrations of phthalates.”

    From A Review of Biomonitoring of Phthalate Exposures (2019) · cites this paper as [192]

    The Results (page unavailable) report positive associations for MBP and MiBP in NHSII and for MECPP in the combined cohorts. The claim names MCPP instead of MECPP, and the cited Results do not establish the claimed increase for MBzP; they also state that DEHP metabolites as a group were not significantly associated with incident type 2 diabetes. The Discussion (page unavailable) notes no phthalate association in the older NHS women, so the finding should not be generalized to both cohorts. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 56

  1. Alonso-Magdalena P Morimoto S Ripoll C Fuentes E Nadal A 2006 The estrogenic effect of bisphenol A disrupts pancreatic β-cell function in vivo and induces insulin resistance. Environ Health Perspect 114 106 112; 10.1289/ehp.8451 16393666 PMC1332664 · DOI
  2. Alonso-Magdalena P Ropero AB Carrera MP Cederroth CR Baquie M Gauthier BR 2008 Pancreatic insulin content regulation by the estrogen receptor ERα. PLoS One 3 4 e2069; 10.1371/journal.pone.0002069 18446233 PMC2323613 · DOI
  3. Ben-Jonathan N Hugo ER Brandebourg TD 2009 Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol Cell Endocrinol 304 1–2 49 54 19433247 PMC2775425
  4. Bindhumol V Chitra KC Mathur PP 2003 Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 188 2–3 117 124 12767684
  5. Braun JM Kalkbrenner AE Calafat AM Bernert JT Ye X Silva MJ 2011 Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect 119 131 137; 10.1289/ehp.1002366 21205581 PMC3018492 · DOI · Paper page
  6. Buckley JP Palmieri RT Matuszewski JM Herring AH Baird DD Hartmann KE 2012 Consumer product exposures associated with urinary phthalate levels in pregnant women. J Expo Sci Environ Epidemiol 22 5 468 475 22760436 PMC3439834
  7. Carwile JL Michels KB 2011 Urinary bisphenol A and obesity: NHANES 2003–2006. Environ Res 111 6 825 830 21676388 PMC3747781
  8. Casals-Casas C Desvergne B 2011 Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 73 135 162 21054169
  9. Chen JQ Brown TR Russo J 2009. Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta 1793(7 1128 1143 PMC2747085 19348861
  10. Corton JC Lapinskas PJ 2005 Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract? Toxicol Sci 83 1 4 17 15496498
  11. Desvergne B Feige JN Casals-Casas C 2009 PPAR-mediated activity of phthalates: a link to the obesity epidemic? Mol Cell Endocrinol 304 1–2 43 48 19433246
  12. Durrleman S Simon R 1989 Flexible regression models with cubic splines. Stat Med 8 5 551 561 2657958
  13. Evans RM Barish GD Wang YX 2004 PPARs and the complex journey to obesity. Nat Med 10 4 355 361 15057233
  14. Feige JN Gelman L Rossi D Zoete V Metivier R Tudor C 2007 The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor γ modulator that promotes adipogenesis. J Biol Chem 282 26 19152 19166 17468099
  15. Feige JN Gerber A Casals-Casas C Yang Q Winkler C Bedu E 2010 The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARα-dependent mechanisms. Environ Health Perspect 118 234 241; 10.1289/ehp.0901217 20123618 PMC2831923 · DOI
  16. Fox SD Falk RT Veenstra TD Issaq HJ 2011 Quantitation of free and total bisphenol A in human urine using liquid chromatography-tandem mass spectrometry. J Sep Sci 34 11 1268 1274 21506272
  17. Gayathri NS Dhanya CR Indu AR Kurup PA 2004 Changes in some hormones by low doses of di (2-ethyl hexyl) phthalate (DEHP), a commonly used plasticizer in PVC blood storage bags & medical tubing. Indian J Med Res 119 4 139 144 15147118
  18. Geens T Aerts D Berthot C Bourguignon JP Goeyens L Lecomte P 2012 A review of dietary and non-dietary exposure to bisphenol-A. Food Chem Toxicol 50 10 3725 3740 22889897
  19. Hatch EE Nelson JW Qureshi MM Weinberg J Moore LL Singer M 2008 Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999–2002. Environ Health 7 27; 10.1186/1476-069X-7-27 18522739 PMC2440739 · DOI · Paper page
  20. Hauser R Calafat AM 2005 Phthalates and human health. Occup Environ Med 62 11 806 818 16234408 PMC1740925
  21. Hugo ER Brandebourg TD Woo JG Loftus J Alexander JW Ben-Jonathan N 2008 Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 116 1642 1647; 10.1289/ehp.11537 19079714 PMC2599757 · DOI
  22. James-Todd T Stahlhut R Meeker JD Powell SG Hauser R Huang T 2012 Urinary phthalate metabolite concentrations and diabetes among women in the National Health and Nutrition Examination Survey (NHANES) 2001–2008. Environ Health Perspect 120 1307 1313; 10.1289/ehp.1104717 22796563 PMC3440117 · DOI
  23. Kato K Silva MJ Needham LL Calafat AM 2005 Determination of 16 phthalate metabolites in urine using automated sample preparation and on-line preconcentration/high-performance liquid chromatography/tandem mass spectrometry. Anal Chem 77 9 2985 2991 15859620
  24. Kelley KE Hernández-Díaz S Chaplin EL Hauser R Mitchell AA 2012 Identification of phthalates in medications and dietary supplement formulations in the United States and Canada. Environ Health Perspect 120 379 384. 10.1289/ehp.1103998 22169271 PMC3295354 · DOI
  25. Kuiper GG Carlsson B Grandien K Enmark E Haggblad J Nilsson S 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138 3 863 870 9048584
  26. LaKind JS Goodman M Naiman DQ 2012 Use of NHANES data to link chemical exposures to chronic diseases: a cautionary tale. PLoS One 7 12 e51086; 10.1371/journal.pone.0051086 23227235 PMC3515548 · DOI
  27. Lang IA Galloway TS Scarlett A Henley WE Depledge M Wallace RB 2008 Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300 11 1303 1310 18799442
  28. Lapinskas PJ Brown S Leesnitzer LM Blanchard S Swanson C Cattley RC 2005 Role of PPARα in mediating the effects of phthalates and metabolites in the liver. Toxicology 207 1 149 163 15590130
  29. Lemmen JG Arends RJ van der Saag PT van der Burg B 2004 In vivo imaging of activated estrogen receptors in utero by estrogens and bisphenol A. Environ Health Perspect 112 1544 1549; 10.1289/ehp.7155 15531440 PMC1247619 · DOI
  30. Lind PM Roos V Rönn M Johansson L Ahlström H Kullberg J 2012a Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly women. Environ Health 11 21; 10.1186/1476-069X-11-21 22472124 PMC3379932 · DOI
  31. Lind PM Zethelius B Lind L 2012b Circulating levels of phthalate metabolites are associated with prevalent diabetes in the elderly. Diabetes Care 35 7 1519 1524 22498808 PMC3379584
  32. Manson JE Rimm EB Stampfer MJ Colditz GA Willett WC Krolewski AS 1991 Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338 8770 774 778 1681160
  33. McCullough ML Feskanich D Stampfer MJ Giovannucci EL Rimm EB Hu FB 2002 Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 76 6 1261 1271 12450892
  34. Melzer D Osborne NJ Henley WE Cipelli R Young A Money C 2012 Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 125 12 1482 1490 22354940
  35. Nadal A Alonso-Magdalena P Soriano S Quesada I Ropero AB 2009 The pancreatic β-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 304 1–2 63 68 19433249
  36. Nadal A Ropero AB Laribi O Maillet M Fuentes E Soria B 2000 Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor β. Proc Natl Acad Sci USA 97 21 11603 11608 11027358 PMC17247
  37. Nakagawa Y Tayama S 2000 Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes. Arch Toxicol 74 2 99 105 10839477
  38. Ning G Bi Y Wang T Xu M Xu Y Huang Y 2011 Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in Chinese adults: a cross-sectional analysis. Ann Intern Med 155 6 368 374 21930854
  39. Qi L Hu FB Hu G 2008 Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr Mol Med 8 6 519 532 18781959
  40. Quesada I Fuentes E Viso-León MC Soria B Ripoll C Nadal A 2002 Low doses of the endocrine disruptor bisphenol-A and the native hormone 17β-estradiol rapidly activate transcription factor CREB. FASEB J 16 12 1671 1673 12207000
  41. Rengarajan S Parthasarathy C Anitha M Balasubramanian K 2007 Diethylhexyl phthalate impairs insulin binding and glucose oxidation in Chang liver cells. Toxicol In Vitro 21 1 99 102 16956746
  42. Ropero AB Alonso-Magdalena P García-García E Ripoll C Fuentes E Nadal A 2008 Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 31 2 194 200 17971160
  43. Rothman KJ, Greenland S. 1998 Modern Epidemiology. 2nd ed Philadelphia Lippincott Williams & Wilkins
  44. Shankar A Teppala S 2011 Relationship between urinary bisphenol A levels and diabetes mellitus. J Clin Endocrinol Metab 96 12 3822 3826 21956417 PMC3232607
  45. Silva MJ Barr DB Reidy JA Malek NA Hodge CC Caudill SP 2004 Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999–2000. Environ Health Perspect 112 331 338 14998749 PMC1241863
  46. Silver MK O’Neill MS Sowers MR Park SK 2011 Urinary bisphenol A and type-2 diabetes in U.S. adults: data from NHANES 2003–2008. PLoS One 6 10 e26868; 10.1371/journal.pone.0026868 22046388 PMC3202589 · DOI
  47. Snijder CA Heederik D Pierik FH Hofman A Jaddoe VW Koch HM 2013 Fetal growth and prenatal exposure to bisphenol A: the generation R study. Environ Health Perspect 121 393 398; 10.1289/ehp.1205296 23459363 PMC3621207 · DOI
  48. Soriano S Alonso-Magdalena P García-Arévalo M Novials A Muhammed SJ Salehi A 2012 Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor β. PLoS One 7 2 e31109; 10.1371/journal.pone.0031109 22347437 PMC3275611 · DOI
  49. Sugiyama S Shimada N Miyoshi H Yamauchi K 2005 Detection of thyroid system-disrupting chemicals using in vitro and in vivo screening assays in Xenopus laevis. Toxicol Sci 88 2 367 374 16179385
  50. Sun Q, Cornelis MC, Manson JE, Hu FB. 2013 Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes 62 1 49 55 22923470 PMC3526056
  51. Svensson K Hernández-Ramírez RU Burguete-García A Cebrián ME Calafat AM Needham LL 2011 Phthalate exposure associated with self-reported diabetes among Mexican women. Environ Res 111 6 792 796 21696718 PMC5240471
  52. Teitelbaum SL Mervish N Moshier EL Vangeepuram N Galvez MP Calafat AM 2012 Associations between phthalate metabolite urinary concentrations and body size measures in New York City children. Environ Res 112 186 193 22222007 PMC3267869
  53. Townsend MK Franke AA Li X Hu FB Eliassen AH 2013 Within-person reproducibility of urinary bisphenol A and phthalate metabolites over a 1 to 3 year period among women in the Nurses’ Health Studies: a prospective cohort study. Environ Health 12 1 80; 10.1186/1476-069X-12-80 24034517 PMC3847616 · DOI
  54. Trasande L Attina TM Blustein J 2012 Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 308 11 1113 1121 22990270
  55. Wozniak AL Bulayeva NN Watson CS 2005 Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-α–mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect 113 431 439; 10.1289/ehp.7505 15811834 PMC1278483 · DOI
  56. Zsarnovszky A Le HH Wang HS Belcher SM 2005 Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 146 12 5388 5396 16123166

Cited by

Sorted by citations

Authors
Sun, Q., Cornelis, M. C., Townsend, M. K., Tobias, D. K., Eliassen, A. H., Franke, A. A., Hauser, R., & Hu, F. B.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
  • University of Hawaii Cancer Center (US)
Corresponding author
Sun, Qi
Venue
Environmental Health Perspectives
Published
2014-03-14
Volume
122
Issue
6
Pages
616-623
ISSN
  • 0091-6765 (ISSN-L)
  • 1552-9924
OpenAlex
W1968705853
Cited by
274
References
2
Citations by year
2026: 15 · 2025: 19 · 2024: 24 · 2023: 25 · 2022: 19 · 2021: 41 · 2020: 21 · 2019: 23 · 2018: 22 · 2017: 16 · 2016: 23 · 2015: 19 · 2014: 5
FWCI
13.81
Type
journal article
Language
en
Open access
Locations
  • Environmental Health Perspectives (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • National Institutes of Health (5r01ca049449-18)
  • National Heart, Lung, and Blood Institute (R01HL035464, R00HL098459)
  • National Cancer Institute (CA-49449, CA-87969, U01CA067262, CA67262, P01CA087969, R01‐CA049449, CA50385, R01CA050385, U01CA049449, R01CA067262, P30CA071789)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058785, R56DK058785, R01DK058845, DK-082486, DK 58785, R01DK082486, DK58845)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
Keywords
type 2 diabetes, bisphenol A, phthalate metabolites, urinary biomarkers, endocrine disruptors, body mass index, DEHP, diabetes risk, Nurses' Health Study, Nurses' Health Study II, prospective cohort
MeSH terms
Bisphenol A Compounds, Aged, Benzhydryl Compounds, Diabetes Mellitus, Type 2, Environmental Exposure, Environmental Pollutants, Female, Humans, Middle Aged, Phenols, Phthalic Acids, Risk Factors, Body Mass Index, Epidemiologic Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review